Psyence Biomedical Ltd. (PBM)
USD 1.53
(-12.57%)
USD 1.53
(-12.57%)
| Breakdown | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | 240.00 | - | - |
| Gross Profit | -240.00 | - | - |
| Operating Expenses | 2.75 Million | 1.29 Million | 334.28 Thousand |
| Selling, General and Administrative Expenses | 1.79 Million | 1.29 Million | 334.28 Thousand |
| Research and Development Expenses | 954.59 Thousand | 1.6 Million | 137.23 Thousand |
| Other Expenses | 879.34 Thousand | - | - |
| Cost and Expenses | 2.75 Million | 1.29 Million | 334.28 Thousand |
| Operating Income | -2.75 Million | -1.29 Million | -334.29 Thousand |
| Interest Expense | 52.94 Thousand | - | - |
| Income Tax Expense | - | - | - |
| Earnings before Tax | -51.15 Million | 8.01 Million | 8.23 Million |
| Net Income | -51.15 Million | 8.01 Million | 8.23 Million |
| Earnings Per Share Basic | -7.85 | -0.64 | - |
| Earnings Per Share Diluted | -7.85 | -0.64 | - |
| Weighted Average Shares Outstanding | 6.51 Million | 5 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 6.51 Million | 5 Million | - |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | -2.75 Million | -1.29 Million | -334.29 Thousand |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 240.00 | - | - | - | - | - |
| Gross Profit | -240.00 | - | - | - | - | - |
| Operating Expenses | 2.75 Million | 632.1 Thousand | 557.05 Thousand | 512.08 Thousand | 771.49 Thousand | 1.29 Million |
| Selling, General and Administrative Expenses | - | 556.96 Thousand | 557.05 Thousand | 512.08 Thousand | 771.49 Thousand | - |
| Research and Development Expenses | - | 75.13 Thousand | - | - | - | - |
| Other Expenses | 879.34 Thousand | - | - | - | - | - |
| Cost and Expenses | 2.75 Million | 632.1 Thousand | 557.05 Thousand | 512.08 Thousand | 771.49 Thousand | 1.29 Million |
| Operating Income | -2.75 Million | -632.1 Thousand | -557.05 Thousand | -512.09 Thousand | -771.49 Thousand | -1.29 Million |
| Interest Expense | 52.94 Thousand | - | - | - | - | - |
| Income Tax Expense | - | -118.00 | - | - | - | - |
| Earnings before Tax | -51.15 Million | -24.76 Million | -647.76 Thousand | -62.84 Thousand | -24.48 Thousand | 8.01 Million |
| Net Income | -51.15 Million | -24.76 Million | -647.76 Thousand | -62.84 Thousand | -24.48 Thousand | 8.01 Million |
| Earnings Per Share Basic | - | -1.85 | -0.08 | -0.01 | -0.00 | - |
| Earnings Per Share Diluted | - | -1.85 | -0.08 | -0.01 | -0.00 | - |
| Weighted Average Shares Outstanding | 6.51 Million | 13.39 Million | 7.69 Million | 8.03 Million | 11.43 Million | 32.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.51 Million | 13.39 Million | 7.69 Million | 8.03 Million | 11.43 Million | 32.67 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -632.1 Thousand | -557.05 Thousand | -512.09 Thousand | -771.49 Thousand | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
SPIC
206560
ROS
ALNY
ESR
603118